Publications

Export 190 results:
Sort by: Author Title Type [ Year  (Desc)]
2006
El-Raziky, M., W. El-Akel, M. Soliman, S. El-Kafrawy, M. Abdel-Hamid, and G. Esmat. "HCV relapse in sustained responders to interferon therapy for chronic hepatitis C genotype 4." JOURNAL OF CLINICAL VIROLOGY 36 (2006): S141. Abstract
n/a
Mohamed, M. K., I. Bakr, M. El-Houssinie, N. Arafa, A. Hassan, S. Ismail, M. Anwar, M. Attala, C. Rekacewicz, K. Zalata et al. "HCV-related morbidity in a rural community of Egypt." JOURNAL OF CLINICAL VIROLOGY 36 (2006): S131. Abstract
n/a
Esmat, G., K. Zalata, M. A. Metwally, H. Khattab, M. El Batanouni, M. El Daly, M. Anwar, A. Hassan, S. Ismail, M. Said et al. "Histopathological characterization of genotype 4 chronic hepatitis C." JOURNAL OF CLINICAL VIROLOGY 36 (2006): S106-S107. Abstract
n/a
Ismail, S. A., M. K. Mohamed, H. Mansour, C. Rekacewicz, R. R. Gad, M. El-Houssinie, Sharaf N. M. El-Din, M. El-Daly, S. El-Kafrawy, M. Abdel-Hamid et al. "Pegylated interferon alpha-2a for treatment of acute hepatitis C in Egypt (ANRS 1213 trial)." JOURNAL OF CLINICAL VIROLOGY 36 (2006): S137. Abstract
n/a
Esmat, G., H. El Makhzangy, S. Males, R. R. Gad, C. Rekacewicz, S. A. Ismail, M. Abdel-Hamid, M. El-Daly, S. Pol, A. Fontanet et al. "Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)." JOURNAL OF CLINICAL VIROLOGY 36 (2006): S138. Abstract
n/a
Metwally, M. A., A. Youssef, Abdel K. Qawi, I. Rageh, Abdel M. Hamid, A. Shaheen, and G. Esmat. "Prevalence and risk factors of hepatitis C among pregnant females in Egypt." JOURNAL OF CLINICAL VIROLOGY 36 (2006): S204. Abstract
n/a
Males, S., R. R. Gad, G. Esmat, M. Said, C. Rekacewicz, K. Zalata, M. Abdel-Hamid, P. Bedossa, S. Pol, M. K. Mohamed et al. "Serum alpha-fetoprotein (AFP) level predicts treatment outcome in chronic hepatitis C (ANRS 1211)." JOURNAL OF CLINICAL VIROLOGY 36 (2006): S133. Abstract
n/a
Bakr, I., C. Rekacewicz, M. El Hosseiny, S. Ismail, M. El Daly, S. El-Kafrawy, G. Esmat, MA Hamid, M. K. Mohamed, and A. Fontanet. "Higher clearance of hepatitis C virus infection in females compared with males." GUT 55 (2006): 1183-1187. Abstract
n/a
Ibrahim, Sherif A., Sayed F. Abdelwahab, Mona M. Mohamed, Ahmed M. Osman, Eman Fathy, Kamal S. Al-Badry, Nabil Al-Kady, Gamal Esmat, and Maged M. Al-Sherbiny. "T cells are depleted in HCV-induced hepatocellular carcinoma patients: possible role of apoptosis and p53." RETROVIROLOGY 3 (2006). Abstract
n/a
2005
Esmat, G., A. Yosry, M. El-Serafi, A. Omar, W. Doss, A. Hosny, A. Ghali, H. Sabry, H. Attia, S. Kamel et al. "Donor outcomes in right lobe adult living donor liver transplantation: Single-center experience in Egypt." TRANSPLANTATION PROCEEDINGS 37 (2005): 3147-3150. Abstract
n/a
El-Raziky, M. S., WA El-Akel, M. A. Soliman, S. El-Kafrawy, M. Abdel-Hamid, and G. Esmat. "HCV RNA in peripheral blood mononuclear cells (PBMNCS) of sustained virological responders to interferon based therapies: Is it a risk for relapse?" HEPATOLOGY 42 (2005): 431A. Abstract
n/a
Nada, O., M. Abdel-Hamid, A. Ismail, L. El Shabrawy, KFS Sidhom, NMA El Badawy, FAA Ghazal, M. El Daly, S. El Kafrawy, G. Esmat et al. "The role of the tumor necrosis factor (TNF) - Fas L and HCV in the development of hepatocellular carcinoma." JOURNAL OF CLINICAL VIROLOGY 34 (2005): 140-146. Abstract
n/a
Yosry, A., W. Doss, A. Abdel-Bary, G. Esmat, M. El-Serafy, E. Omar, A. El-Tawil, A. Ghaly, A. Hosny, S. Rifaat et al. "Hepatitis C virus genotype 4 recurrence in Egyptian living donor liver transplant recipients." LIVER TRANSPLANTATION 11 (2005): C19. Abstract
n/a
Abdelaziz, AO, AY Hamad, G. Esmat, M. A-Serafy, W. Doss, A. Hosny, A. Ansary, and K. Tanaka. "Tacrolimus (FK 506) toxicity in the early postoperative period following living donor liver transplantation (LDLT) among Egyptian adults: Limited experiance." LIVER TRANSPLANTATION 11 (2005): C44. Abstract
n/a
El Makhzangy, H., C. Rekacewicz, SI Shouman, HN Mohamed, G. Esmat, A. Ismail, R. Rafaat, M. El Hosseiny, M. El Daly, S. El Kafrawy et al. "Combined pegylated interferon alpha-2a and ribavirin in treatment of chronic hepatitis C in Egypt (ANRS 1211 trial)." JOURNAL OF HEPATOLOGY 42 (2005): 203. Abstract
n/a
Elmakhzangy, HI, C. Rekacewicz, S. Shouman, HN Mohamed, G. Esmat, AA Mansour, A. Ismail, R. Rafaat, M. El Hosseiny, M. El Daly et al. "Early predictors of sustained viral response (SVR) in chronic hepatitis C (Genotype 4) patients treated with pegylated interferon alpha-2a and ribavirin." GASTROENTEROLOGY 128 (2005): A714. Abstract
n/a
Yosry, A., Y. El-Sharif, A. Hendawi, G. Esmat, M. Salah, and S. Zakaria. "Hepatic cyclooxygenase (COX)-2 and response to combined Interferon & Ribavirin therapy in chronic hepatitis C." JOURNAL OF HEPATOLOGY 42 (2005): 228. Abstract
n/a
Shouman, SI, M. K. Mohamed, G. Esmat, M. Attalla, H. Mansour, C. Rekacewicz, R. Rafaat, N. Sharaf, M. El Hosseiny, M. El Daly et al. "Pegylated interfon for treatment of acute hepatitis C in Egypt (ANRS 1213 trial)." JOURNAL OF HEPATOLOGY 42 (2005): 221. Abstract
n/a
2004
El-Raziky, M. S., M. El-Hawary, N. El-Koofy, S Okasha, M Isa, M. Kotb, K. Salama, G. Esmat, M. El-Raziky, A. M. Abouzied, and H. El-Karaksy. "Hepatitis C virus infection in Egyptian children: single centre experience." JOURNAL OF VIRAL HEPATITIS 11 (2004): 471-476. Abstract
n/a
Elmakhzangy, HI, G. Esmat, M. Alraziky, ESA Aoun, and M. K. Mohamed. "Hepatocellular carcinoma: The magnitude of the problem in Egypt." GASTROENTEROLOGY 126 (2004): A718. Abstract
n/a
2003
Esmat, GH, A. Abouzied, M. Abdel-Hamid, M. K. Mohamed, K. Zalata, MS El Raziky, SA Ismael, M. Said, A. Hasan, M. Anwar et al. "Results of a randomized clinical trial of genotype-4 infected subjects when treated with standard or pegylated interferon alfa-2b in combination with ribavirin." HEPATOLOGY 38 (2003): 314A-315A. Abstract
n/a
Esmat, G., M. K. Mohamed, MA Hamid, K. Zalata, H. Khatab, M. El Batanony, A. M. Abouzied, M. El Raziky, AM Shaheen, A. Ismail et al. "The impact of steatosis on baseline characteristic and end of treatment response for chronic hepatitis (C) genotype 4 patients treated with interferon." JOURNAL OF HEPATOLOGY 38 (2003): 139. Abstract
n/a
2002
Esmat, G., S. Zakaria, H. Khatab, M. Abdel-Hamid, M. Anwar, M. El-Razki, M. El-Daly, S. El-Kafrawy, A. Hasan, A. Shaheen et al. "Impact of hepatitis C virus (HCV) genotype and viral load on the biochemical and histopathological liver profiles in Egyptian patients infected with HCV." HEPATOLOGY 36 (2002): 535A. Abstract
n/a
Strickland, GT, H. Elhefni, T. Salman, I. Waked, M. Abdel-Hamid, NNH Mikhail, G. Esmat, and A. Fix. "Role of hepatitis C infection in chronic liver disease in Egypt." AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 67 (2002): 436-442. Abstract
n/a
Esmat, G., A. M. Abouzied, F. Abdel-Aziz, M. K. Mohamed, M. Abdel-Hamid, MS El Raziky, S. A. Ismail, KR Zalata, NN Mikhail, A. Fix et al. "Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4." HEPATOLOGY 36 (2002): 364A. Abstract
n/a
Tourism